Retour aux projets

13766.3 PFLS-LS

13766.3 PFLS-LS

Résumé

Erythrocyte-binding Uricase for Inducing Immunological Tolerance

Textes supplémentaires

Abstract

A protein engineering technology will be developed for induction of antigen-specific immunological tolerance,|applicable for tolerance to protein drugs and to autoimmunity antigens. In this project, the technology will be|developed in the context of reducing the unwanted immunogenicity reactions towards the therapeutic protein|drug uricase (urate oxidase, Rasburicase), by engineering tolerogenic forms of uricase and thus enabling|safe treatment of tumor lysis syndrome and gout.

Participants

Oscar Buset

Wirtschaftspartner

oscar@anokion.com

Anokion SA Oscar Buset Chemin des Condémines 22 B 1028 Préverenges VD CH

Jeffrey Hubbell

Kontaktperson

jeffrey.hubbell@epfl.ch

EPFL SV IBI LMRP Jeffrey Hubbell Station 15 1015 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2013-04-30
Date de fin
2015-10-31
Coûts totaux approuvés
CHF 559523.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%